We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+12.4%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$335M
AUM Growth
+$66.6M
Cap. Flow
+$40.8M
Cap. Flow %
12.18%
Top 10 Hldgs %
10.51%
Holding
476
New
121
Increased
122
Reduced
81
Closed
105

Top Buys

Rank Stock Value
1
MGRC icon
McGrath RentCorp
MGRC
+$2.84M
2
HGV icon
Hilton Grand Vacations
HGV
+$2.81M
3
SCS
Steelcase
SCS
+$2.56M
4
FBP icon
First Bancorp
FBP
+$2.21M
5
NSP icon
Insperity
NSP
+$2.16M

Top Sells

Rank Stock Value
1
AXE
Anixter International Inc
AXE
+$3.4M
2
KEYS icon
Keysight
KEYS
+$2.72M
3
MTZ icon
MasTec
MTZ
+$2.7M
4
GMS
GMS Inc
GMS
+$2.48M
5
HD icon
Home Depot
HD
+$2.29M

Sector Composition

Rank Sector Weight
1 Industrials 19.63%
2 Technology 18.16%
3 Healthcare 15.63%
4 Consumer Discretionary 14.53%
5 Financials 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNH
451
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-3,917
Closed -$208K
BNFT
452
DELISTED
Benefitfocus, Inc.
BNFT
-13,979
Closed -$333K
AGTC
453
DELISTED
Applied Genetic Technologies Corporation
AGTC
-14,740
Closed -$61K
CCXI
454
DELISTED
ChemoCentryx, Inc.
CCXI
-34,460
Closed -$234K
ENDP
455
DELISTED
Endo International plc
ENDP
-31,707
Closed -$102K
SREV
456
DELISTED
ServiceSource International, Inc.
SREV
-20,858
Closed -$18K
PSB
457
DELISTED
PS Business Parks, Inc.
PSB
-11,503
Closed -$2.09M
SRRA
458
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-1,992
Closed -$31K
INFO
459
DELISTED
IHS Markit Ltd. Common Shares
INFO
-4,149
Closed -$277K
INOV
460
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-41,651
Closed -$683K
MSGN
461
DELISTED
MSG Networks Inc.
MSGN
-44,189
Closed -$717K
HMSY
462
DELISTED
HMS Holdings Corp.
HMSY
-11,640
Closed -$401K
ONDK
463
DELISTED
On Deck Capital, Inc.
ONDK
-30,835
Closed -$104K
BREW
464
DELISTED
Craft Brew Alliance, Inc.
BREW
-33,697
Closed -$276K
DZSI
465
DELISTED
DZS Inc. Common Stock
DZSI
-10,860
Closed -$99K
GNC
466
DELISTED
GNC Holdings, Inc.
GNC
-95,910
Closed -$205K
AXE
467
DELISTED
Anixter International Inc
AXE
-49,244
Closed -$3.4M
TUES
468
DELISTED
Tuesday Morning Corp
TUES
-13,850
Closed -$22K
RARX
469
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-13,880
Closed -$328K
AKS
470
DELISTED
AK Steel Holding Corp
AKS
-75,225
Closed -$171K
DERM
471
DELISTED
Dermira, Inc.
DERM
-39,090
Closed -$250K
IPHS
472
DELISTED
Innophos Holdings, Inc.
IPHS
-14,901
Closed -$484K
ACHN
473
DELISTED
Achillion Pharmaceuticals
ACHN
-24,036
Closed -$87K
OLBK
474
DELISTED
Old Line Bancshares, Inc.
OLBK
-8,870
Closed -$257K
MEET
475
DELISTED
The Meet Group, Inc. Common Stock
MEET
-94,750
Closed -$310K

Similar funds

Algert Global's Q4 2019 Portfolio in Review

As of Q4 2019, Algert Global held 476 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Algert Global deployed $40.8M of net new capital in Q4 2019, opening 121 new positions and adding to 122 existing holdings. Its largest new stake was McGrath RentCorp: 39,097 shares worth $2.99M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was MasTec, an estimated $2.7M trimmed.

  • Algert Global's largest Q4 2019 buy was McGrath RentCorp: 39,097 shares worth $2.99M.
  • Algert Global added most to ePlus in Q4 2019, an estimated $2.08M increase.
  • Algert Global's biggest Q4 2019 reduction was MasTec, cutting an estimated $2.7M.
  • Algert Global fully exited Anixter International Inc in Q4 2019, selling an estimated $3.4M.
  • Algert Global's ten largest holdings make up 11% of its $335M portfolio in Q4 2019.
  • Algert Global opened 121 new positions and closed 105 in Q4 2019.
  • Algert Global's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Algert Global's 13F filing for Q4 2019, filed 18 Feb 2020.